<DOC>
	<DOCNO>NCT00156741</DOCNO>
	<brief_summary>The purpose study provide evidence Refined Ventricular Pacing Algorithm lead clinically relevant reduction ( least 50 % reduction ) incidence ventricular pacing .</brief_summary>
	<brief_title>Efficacy Pacemaker Algorithm Promotion Intrinsic Heart Activity .</brief_title>
	<detailed_description>Electrical stimulation apex right ventricle ( ventricular pacing ) usually improve heart function patient pacemaker even life-saving . However , evidence accumulate ventricular pacing may also undesired long-term cardiac effect . Therefore , make sense limit ventricular pace absolute require minimum . The functionality RVP ( Refined Ventricular Pacing ) C-series 2nd generation pacemaker Vitatron B.V. Arnhem , Netherlands design reduce ventricular pacing . After implantation Vitatron C50 D model C50A2 ( pacemaker ) Vitatron C60 DR model C60A2 ( pacemaker ) 4-6 week stabilization period , proper function pacemaker lead ( stimulation- sensing parameter ) check . The pacemaker program accord predefined setting . In follow 4-weeks Baseline period diagnostic data ( atrial fibrillation burden percentage ventricular pacing ( % VP ) ) collect pacemaker memory . Based data , patient exclude participation ( patient 15 % atrial fibrillation ) subdivide three group : ( ) &lt; 30 % VP ( 30- VP group ) , ( b ) &gt; 30 % VP , Sick Sinus Syndrome normal conductivity ( SSS group ) , ( c ) &gt; 30 % VP , 1st 2nd degree AV block . Patients three group treat 4 week alternatively RVP functionality switch ON OFF . The order determine randomization . At end two cross-over period % VP judgment patient last period assess . Adverse event record moment study enrolment .</detailed_description>
	<mesh_term>Bradycardia</mesh_term>
	<mesh_term>Sick Sinus Syndrome</mesh_term>
	<criteria>Patients shall willing sign Patient Informed Consent study Patients shall least one follow indication pacemaker : Sick Sinus Syndrome normal QRS complex First degree AV block PR interval &lt; _220 m patient &lt; _ 70 year age , &lt; _ 260 patient 70 year Seconddegree AV block , mobitz I ( wenckebach ) mobitz II Patients shall available followup duration participation . Patients involve another investigation study conduct parallel study Patients young 18 year age and/or patient NOT meet local requirement participation Pregnant patient Patients lead integrity problem ( lead replace ) Patients persistant AF Patients complete AV block Patients NYHA ( New York Heart Association0 class III IV Patients underwent thoracic surgery last three month expect near future Patients 2:1 block Patients life expectancy less half year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2005</verification_date>
	<keyword>Refined ventricular pacing</keyword>
</DOC>